FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016370501> ?p ?o ?g. }

• W2016370501 endingPage "1110" @default.
• W2016370501 startingPage "1101" @default.
• W2016370501 abstract "Mutated transthyretin (TTR) fibrils are associated with the pathology of familial amyloidotic polyneuropathy (FAP), in which extracellular amyloid deposits lead to degeneration of cells and tissues, in particular neurons of the peripheral nerve. Here we present evidence that the receptor for advanced glycation end products (RAGE), previously associated with Alzheimer's disease, acts as a selective cell surface acceptor site for both soluble and fibrillar TTR. Immunohistochemical studies demonstrating increased expression of RAGE in FAP tissues suggested the relevance of this receptor to TTR-induced fibrillar pathology. In vitro studies using soluble RAGE showed saturable specific interaction with soluble and fibrillar TTR with a K(d) of approximately 120 nM. However, no binding was observed when soluble TTR was combined with retinol-binding protein, which represents the form in which TTR normally circulates in plasma. Specific binding of TTR to RAGE-transfected Chinese hamster ovary cells (which was completely blocked by anti-RAGE) was observed, confirming that RAGE could mediate TTR binding to cellular surfaces. RAGE-dependent activation of nuclear transcription factor kB (NF-kB) by TTR fibrils was shown in PC-12 cells stably transfected to overexpress the receptor. Furthermore, FAP nerves showed up-regulation of p50, one of the NF-kB subunits, when compared with age-matched controls. From these observations we predict that, in vivo, the presence of TTR fibrils associated with cellular surfaces of FAP patients, by contributing to NF-kB activation, leads to the pathogenesis of neurodegeneration. Further insights into the consequences of the interaction of fibrillar TTR with RAGE may therefore provide a better understanding of neurodegeneration associated with FAP." @default.
• W2016370501 created "2016-06-24" @default.
• W2016370501 creator A5011688843 @default.
• W2016370501 creator A5012675757 @default.
• W2016370501 creator A5034241498 @default.
• W2016370501 creator A5071638419 @default.
• W2016370501 date "2000-07-01" @default.
• W2016370501 modified "2023-10-11" @default.
• W2016370501 title "Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) Activation" @default.
• W2016370501 cites W1503258737 @default.
• W2016370501 cites W1533421793 @default.
• W2016370501 cites W1550642408 @default.
• W2016370501 cites W1568589356 @default.
• W2016370501 cites W1572011530 @default.
• W2016370501 cites W1955730586 @default.
• W2016370501 cites W1972094490 @default.
• W2016370501 cites W1974280458 @default.
• W2016370501 cites W1975904672 @default.
• W2016370501 cites W1982652047 @default.
• W2016370501 cites W1984830754 @default.
• W2016370501 cites W1993243592 @default.
• W2016370501 cites W2003742797 @default.
• W2016370501 cites W2005640704 @default.
• W2016370501 cites W2006160591 @default.
• W2016370501 cites W2007246738 @default.
• W2016370501 cites W2015654033 @default.
• W2016370501 cites W2023531011 @default.
• W2016370501 cites W2035580449 @default.
• W2016370501 cites W2038611817 @default.
• W2016370501 cites W2043290117 @default.
• W2016370501 cites W2049167261 @default.
• W2016370501 cites W2057616008 @default.
• W2016370501 cites W2061500679 @default.
• W2016370501 cites W2065407080 @default.
• W2016370501 cites W2070117026 @default.
• W2016370501 cites W2071675524 @default.
• W2016370501 cites W2079026827 @default.
• W2016370501 cites W2094765619 @default.
• W2016370501 cites W2098587915 @default.
• W2016370501 cites W2106697731 @default.
• W2016370501 cites W2117690477 @default.
• W2016370501 cites W2123446167 @default.
• W2016370501 cites W2137399373 @default.
• W2016370501 cites W2149342137 @default.
• W2016370501 cites W2158748165 @default.
• W2016370501 doi "https://doi.org/10.1038/labinvest.3780116" @default.
• W2016370501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10908156" @default.
• W2016370501 hasPublicationYear "2000" @default.
• W2016370501 type Work @default.
• W2016370501 sameAs 2016370501 @default.
• W2016370501 citedByCount "159" @default.
• W2016370501 countsByYear W20163705012012 @default.
• W2016370501 countsByYear W20163705012013 @default.
• W2016370501 countsByYear W20163705012014 @default.
• W2016370501 countsByYear W20163705012015 @default.
• W2016370501 countsByYear W20163705012016 @default.
• W2016370501 countsByYear W20163705012017 @default.
• W2016370501 countsByYear W20163705012018 @default.
• W2016370501 countsByYear W20163705012019 @default.
• W2016370501 countsByYear W20163705012020 @default.
• W2016370501 countsByYear W20163705012021 @default.
• W2016370501 countsByYear W20163705012022 @default.
• W2016370501 countsByYear W20163705012023 @default.
• W2016370501 crossrefType "journal-article" @default.
• W2016370501 hasAuthorship W2016370501A5011688843 @default.
• W2016370501 hasAuthorship W2016370501A5012675757 @default.
• W2016370501 hasAuthorship W2016370501A5034241498 @default.
• W2016370501 hasAuthorship W2016370501A5071638419 @default.
• W2016370501 hasBestOaLocation W20163705011 @default.
• W2016370501 hasConcept C104317684 @default.
• W2016370501 hasConcept C121157162 @default.
• W2016370501 hasConcept C126322002 @default.
• W2016370501 hasConcept C134018914 @default.
• W2016370501 hasConcept C147990577 @default.
• W2016370501 hasConcept C153911025 @default.
• W2016370501 hasConcept C169760540 @default.
• W2016370501 hasConcept C170493617 @default.
• W2016370501 hasConcept C175656101 @default.
• W2016370501 hasConcept C185592680 @default.
• W2016370501 hasConcept C2776925932 @default.
• W2016370501 hasConcept C2778857457 @default.
• W2016370501 hasConcept C2779134260 @default.
• W2016370501 hasConcept C54009773 @default.
• W2016370501 hasConcept C55493867 @default.
• W2016370501 hasConcept C71924100 @default.
• W2016370501 hasConcept C86339819 @default.
• W2016370501 hasConcept C86803240 @default.
• W2016370501 hasConcept C95444343 @default.
• W2016370501 hasConceptScore W2016370501C104317684 @default.
• W2016370501 hasConceptScore W2016370501C121157162 @default.
• W2016370501 hasConceptScore W2016370501C126322002 @default.
• W2016370501 hasConceptScore W2016370501C134018914 @default.
• W2016370501 hasConceptScore W2016370501C147990577 @default.
• W2016370501 hasConceptScore W2016370501C153911025 @default.
• W2016370501 hasConceptScore W2016370501C169760540 @default.
• W2016370501 hasConceptScore W2016370501C170493617 @default.
• W2016370501 hasConceptScore W2016370501C175656101 @default.
• W2016370501 hasConceptScore W2016370501C185592680 @default.

• next